Pazopanib in advanced vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysis

References

• Fletcher CDM, Hogendoorn P, Mertens F. eds. WHO classification of tumors of soft tissue and bone (IARC WHO Classification of Tumors). 4th ed. Lyon, France: International Agency for Research on Cancer (IARC); 2013.
   Google Scholar
• Coindre JM, Terrier P, Guillou L, et al. Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group. Cancer 2001;91:1914–26.
   PubMed Web of Science ®Google Scholar
• Ducimetiere F, Lurkin A, Ranchere-Vince D, et al. Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing. PLoS One 2011;6:e20294.
   PubMed Web of Science ®Google Scholar
• Penel N, Bui BN, Bay JO, et al. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study. J Clin Oncol 2008;26:5269–74.
   PubMed Web of Science ®Google Scholar
• Skubitz KM, Haddad PA. Paclitaxel and pegylated-liposomal doxorubicin are both active in angiosarcoma. Cancer 2005;104:361–6.
   PubMed Web of Science ®Google Scholar
• Italiano A, Cioffi A, Penel N, et al. Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas. Cancer 2012;118:3330–6.
   PubMed Web of Science ®Google Scholar
• Young RJ, Natukunda A, Litiere S, et al. First-line anthracycline-based chemotherapy for angiosarcoma and other soft tissue sarcoma subtypes: pooled analysis of eleven European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group trials. Eur J Cancer 2014;50:3178–86.
   PubMed Web of Science ®Google Scholar
• Azzariti A, Porcelli L, Mangia A, et al. Irradiation-induced angiosarcoma and anti-angiogenic therapy: a therapeutic hope?. Exp Cell Res 2014;321:240–7.
   PubMed Web of Science ®Google Scholar
• Agulnik M, Yarber JL, Okuno SH, et al. An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas. Ann Oncol 2013;24:257–63.
   PubMed Web of Science ®Google Scholar
• Ray-Coquard I, Italiano A, Bompas E, et al. Sorafenib for patients with advanced angiosarcoma: a phase II trial from the French Sarcoma Group (GSF/GETO). Oncologist 2012;17:260–6.
   PubMed Web of Science ®Google Scholar
• Maki RG, D'adamo DR, Keohan ML, et al. Phase II study of sorafenib in patients with metastatic or recurrent sarcomas. J Clin Oncol 2009;27:3133–40.
   PubMed Web of Science ®Google Scholar
• Schutz FA, Choueiri TK, Sternberg CN. Pazopanib: clinical development of a potent anti-angiogenic drug. Crit Rev Oncol Hematol 2011;77:163–71.
   PubMed Web of Science ®Google Scholar
• Kasper B, Hohenberger P. Pazopanib: a promising new agent in the treatment of soft tissue sarcomas. Future Oncol 2011;7:1373–83.
   PubMed Web of Science ®Google Scholar
• Sleijfer S, Ray-Coquard I, Papai Z, et al. Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organization for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC study 62043). J Clin Oncol 2009;27:3126–32.
   PubMed Web of Science ®Google Scholar
• van der Graaf WT, Blay JY, Chawla SP, et al. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 2012;379:1879–86.
   PubMed Web of Science ®Google Scholar
• Yoo KH, Kim HS, Lee SJ, et al. Efficacy of pazopanib monotherapy in patients who had been heavily pretreated for metastatic soft tissue sarcoma: a retrospective case series. BMC Cancer 2015;15:154.
   PubMed Web of Science ®Google Scholar
• Fujita M, Endo Y, Fujisawa A, et al. Pazopanib: an alternative in taxane-resistant cutaneous angiosarcoma. Eur J Dermatol 2014;24:267–8.
   PubMed Web of Science ®Google Scholar
• Tomita H, Koike Y, Asai M, et al. Angiosarcoma of the scalp successfully treated with pazopanib. J Am Acad Dermatol 2014;70:e19–21.
   PubMed Web of Science ®Google Scholar
• Kasper B, Sleijfer S, Litiere S, et al. Long-term responders and survivors on pazopanib for advanced soft tissue sarcomas: subanalysis of two European Organization for Research and Treatment of Cancer (EORTC) clinical trials 62043 and 62072. Ann Oncol 2014;25:719–24.
   PubMed Web of Science ®Google Scholar
• Itakura E, Yamamoto H, Oda Y, et al. Detection and characterization of vascular endothelial growth factors and their receptors in a series of angiosarcomas. Journal of Surgical Oncology 2008;97:74–81.
   PubMed Web of Science ®Google Scholar
• Schlemmer M, Reichardt P, Verweij J, et al. Paclitaxel in patients with advanced angiosarcomas of soft tissue: a retrospective study of the EORTC soft tissue and bone sarcoma group. Eur J Cancer 2008;44:2433–6.
   PubMed Web of Science ®Google Scholar
• Stacher E, Gruber-Mosenbacher U, Halbwedl I, et al. The VEGF-system in primary pulmonary angiosarcomas and haemangioendotheliomas: new potential therapeutic targets?. Lung Cancer 2009;65:49–55.
   PubMed Web of Science ®Google Scholar
• Radzikowska E, Szczepulska-Wojcik E, Chabowski M, et al. Pulmonary epithelioid haemangioendothelioma-interferon 2-alpha treatment-case report. Pneumonol Alergol Pol 2008;76:281–5.
   PubMedGoogle Scholar
• Chevreau C, Le Cesne A, Ray-Coquard I, et al. Sorafenib in patients with progressive epithelioid hemangioendothelioma: a phase 2 study by the French Sarcoma Group (GSF/GETO). Cancer 2013;119:2639–44.
   PubMed Web of Science ®Google Scholar
• Sardaro A, Bardoscia L, Petruzzelli MF, et al. Epithelioid hemangioendothelioma: an overview and update on a rare vascular tumor. Oncol Rev 2014;8:259.
   PubMedGoogle Scholar
• Uchida A, Tabata M, Kiura K, et al. Successful treatment of pulmonary artery sarcoma by a two-drug combination chemotherapy consisting of ifosfamide and epirubicin. Jpn J Clin Oncol 2005;35:417–19.
   PubMed Web of Science ®Google Scholar